The management of type 2 diabetes has received significant attention over the past decade due to the increasing prevalence of this condition and the rise in costs associated with its treatment. Approximately 29 million Americans have diabetes, of whom 95% have the type 2 form.

For questions, please contact

2014 Interventions of Interest:

  • Sulfonylureas
  • Insulin
  • Dipeptidyl peptidase-4 (DPP-4) inhibitors
  • Glucagon-like peptide-1 (GLP-1) receptor agonists
  • Continuous blood glucose monitoring

Final Documents

Below you will find the final documents from the assessment review process: